Insulet director granted 1,660 RSUs
INSULET CORP director Timothy J. Scannell received an annual equity award in the form of restricted stock units.
Rhea-AI Filing Summary
INSULET CORP director Timothy J. Scannell received an annual equity award in the form of restricted stock units. The grant covers 1,660 shares of common stock, awarded at no cash cost and recorded as an acquisition of common stock.
The RSUs will be settled in shares of common stock on a one-for-one basis and vest in full on April 30, 2027. After this award, Scannell directly holds 33,024 shares of Insulet common stock, showing this is a routine, compensation-related equity grant rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,660 | $0.00 | $0.00 |
Footnotes (1)
- F1. Annual equity award in the form of restricted stock units ("RSUs"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2027.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Annual equity award financial
Form 4 regulatory
common stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Insulet (PODD) director Timothy J. Scannell report on this Form 4?
When do Timothy J. Scannell’s new Insulet (PODD) RSUs vest?
Was Timothy J. Scannell’s Insulet (PODD) Form 4 a market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.